Skip to main content
. Author manuscript; available in PMC: 2011 May 27.
Published in final edited form as: Cancer Prev Res (Phila). 2009 Apr 28;2(5):440–449. doi: 10.1158/1940-6207.CAPR-08-0136

Table 7.

Toxicities

Toxicity Observation (25 subjects): subjects with toxicity (grade toxicity) 13-Cis RA (22 subjects): subjects with toxicity (grade toxicity) 13-Cis RA/α toco (25 subjects): subjects with toxicity (grade toxicity)
Gastrointestinal 1 (1) 1 (1) 8 (1)
Musculoskeletal 4 (1) 6 (1). 2 (2) 3 (1). 3 (2)
Eye 1 (1) 7 (1), 4 (2) 7 (1), 2 (2)
Skin 6 (1). 2 (2) 7 (1). 5 (2) 18 (1), 6 (2)
Triglyceride 10 (1) 8 (1), 4 (2), 2 (3) 10 (1), 2 (2)
Cholesterol 4 (1) 1 (1) 9 (1), 1 (2)
Glucose 7 (1), 2 (2) 1 (1), 2 (2). 1 (3) 6 (1)
Liver function 9 (1), 2 (2) 10 (1), 2 (2) 17 (1), 1 (2)
Uric acid 6 (1), 1 (3) 5 (1), 4 (2), 1 (4) 4(1), 1 (2). 1 (4)